GENOCEA BIOSCIENCES, INC. — Form D

GENOCEA BIOSCIENCES, INC. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-10-10. The offering totals $400K, of which $400K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (35)

Showing 25 of 35 people.

NameRoleLocation
Kevin BittermanDirectorCambridge, MA
KATRINE BAKER BOSLEYDirectorCAMBRIDGE, MA
WILLIAM BAKER CLARKDirectorCAMBRIDGE, MA
Simeon GeorgeDirectorRedwood City, CA
Stephen HoffmanDirectorVancouver, A1
Robert PaullDirectorBoston, MA
WILLIAM BAKER CLARKExecutive OfficerCAMBRIDGE, MA
ROBERT E FARRELL JR.Executive OfficerCAMBRIDGE, MA
JESSICA BAKER FLECHTNERExecutive OfficerCAMBRIDGE, MA
PAUL BAKER GIANNASCAExecutive OfficerCAMBRIDGE, MA
SETH BAKER HETHERINGTONExecutive OfficerCAMBRIDGE, MA
RAVI BAKER VENKATARAMANIExecutive OfficerCAMBRIDGE, MA
Thomas DavisExecutive OfficerHAMILTON, D0
George SiberDirectorIrvine, CA
William ClarkExecutive OfficerAUSTIN, TX
Ali BehbahaniDirectorLittleton, CO
Leon ChenDirectorAustin, TX
Asish XavierDirectorSouth San Francisco, CA
MICHAEL HIGGINSDirectorFRAMINGHAM, MA
Howard MayerDirectorWaltham, MA
Steve HoffmanDirectorReston, VA
JESSICA FLECHTNERExecutive OfficerCAMBRIDGE, MA
KATRINE BOSLEYDirectorCAMBRIDGE, MA
GIRISH AAKALUExecutive OfficerCAMBRIDGE, MA
DIANTHA DUVALLExecutive OfficerCAMBRIDGE, MA

Other filings by this issuer (5)

FiledFormOfferingSold
2020-08-03D$79.9M$75.5M
2019-02-27D$15.0M$12.1M
2013-07-02D/A$30.5M$30.5M
2012-10-11D$30.5M$15.3M
2011-01-03D$35.1M$35.1M

More